SCHEMBL2167348

SCHEMBL2167348

CC=Cc1ccco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL629218 1.00
SCHEMBL2167346 1.00
SCHEMBL3003413 0.84 F2 (0.56)
SCHEMBL3003418 0.84 F2 (0.56)
SCHEMBL2789580 0.84 ALDH1A1 (0.62)
SCHEMBL641747 0.84 ALDH1A1 (0.62)
SCHEMBL11153607 0.82 F2 (0.55)
SCHEMBL11153560 0.82 F2 (0.55)
SCHEMBL21959834 0.82 HCAR2 (0.39)
SCHEMBL10745928 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118440237-A Self-repairing polymer, preparation method and application thereof, self-repairing coating, cable and communication equipment 武汉烽火锐拓科技有限公司 2024-08-06 CN claimed
US-20160175274-A1 TREATING AN ATYPICAL PROTEIN KINASE C ENZYME ABNORMALITY UNIVERSITY OF SOUTH FLORIDA (US) 2016-06-23 US claimed
US-20080085893-A1 MATRIX METALLOPROTEASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2008-04-10 US claimed
US-6723743-B1 TREATING PATIENT SUFFERING FROM RHEUMATOID ARTHRITIS, PSORIASIS, BRONCHIAL ASTHMA, ALZHEIMER'S DISEASE, MYOCARDIAL INFARCTION OR ATHEROSCLEROSIS NEUROGEN CORPORATION 2004-04-20 US claimed
CN-118440237-A Self-repairing polymer, preparation method and application thereof, self-repairing coating, cable and communication equipment 武汉烽火锐拓科技有限公司 2024-08-06 CN disclosed
US-10688063-B2 Treating and/or preventing insulin-resistance related weight gain UNIVERSITY OF SOUTH FLORIDA (US) 2020-06-23 US disclosed
CN-107311985-B N- [ (3-heterocyclyl) acryloyl ] phenyl nicotinamide derivative and application thereof 西华大学 2019-11-12 CN disclosed
CN-107118185-B N- [ (3-heterocyclic group) acryloyl ] phenyl acrylamide derivative and application thereof 西华大学 2019-05-03 CN disclosed
US-20180028488-A1 TREATING AND/OR PREVENTING INSULIN-RESISTANCE RELATED WEIGHT GAIN UNIVERSITY OF SOUTH FLORIDA (US) 2018-02-01 US disclosed
CN-107311985-A N [(3 heterocyclic radical) acryloyl group] phenyl nicotinamide derivatives and its application 西华大学 2017-11-03 CN disclosed
US-9795584-B2 Treating an atypical protein kinase C enzyme abnormality UNIVERSITY OF SOUTH FLORIDA (US) 2017-10-24 US disclosed
CN-107118185-A N [(3 heterocyclic radical) acryloyl group] phenylacryloyl amine derivants and its application 西华大学 2017-09-01 CN disclosed
EP-0561413-A1 Erythromycin deriatives, preparation and use thereof Takeda Chemical Industries, Ltd. (JP) 1993-09-22 EP disclosed
US-5175150-A Stimulating digective contraction KITASATO, KENKYUSHO (JP) 1992-12-29 US disclosed
US-5008249-A Administering anhydroerythromycin derivative KITASATO KENKYUSHO (JP) 1991-04-16 US disclosed
US-4948782-A A method of promoting the growth of domestic animals with erythromycin derivative containing composition KITASATO KENKYUSHO (JP) 1990-08-14 US disclosed
EP-0186915-B1 NOVEL ALLYLIC AMINES MERRELL DOW PHARMACEUTICALS INC. (US) 1990-08-08 EP disclosed
EP-0215355-A2 Erythromycin derivative and process for preparing the same KITASATO KENKYUSHO (JP) 1987-03-25 EP disclosed
EP-0213617-A2 Digestive tract contractile motion stimulant KITASATO KENKYUSHO (JP) 1987-03-11 EP disclosed
EP-0186915-A2 Novel allylic amines MERRELL DOW PHARMACEUTICALS INC. (US) 1986-07-09 EP disclosed